Jill Marie Fieldhouse, Mba

Total Page:16

File Type:pdf, Size:1020Kb

Jill Marie Fieldhouse, Mba

JILL MARIE FIELDHOUSE, MBA 8 Pacific Avenue Cranford, NJ 07016 908.276.8850 [email protected]

SUMMARY

Senior management strategic advisor with successful track record at Fortune 100 consumer healthcare and pharmaceutical companies. Extensive experience searching, analyzing, presenting, and providing sound recommendations to leverage business opportunities. Provide expert analysis and industry guidance to senior management and partner effectively with all levels in the organization to drive strategic results. Build relationships and leverage network of industry thought leaders and subject matter experts.

 Strategic Thinking  Business Development  Tactical Planning  Brand Analysis  Senior Management Advisor  Business/Scientific Acumen  Business/Competitive Intelligence  Computer Information Specialist

EXPERIENCE

GLAXOSMITHKLINE CONSUMER HEALTHCARE, Parsippany, NJ 2008-2009 Portfolio Manager Consumer healthcare analysis expert supporting major corporate initiatives for strategic growth, large scale acquisitions, and brand expansion/awareness as well as the Breathe RightTM Future Team. Created comprehensive broad-based qualitative/quantitative assessments for senior management.  Designed and executed competitive and scientific/technology assessments for diversified opportunities, including consumer healthcare, pharmaceutical, Rx to OTC switches, device, diagnostic, and intellectual property. Identified pros/cons and made recommendations to leaders and their teams.  Ensured requirements and deliverables were met by external vendors.

JOHNSON & JOHNSON 1997-2007 Manager/Analyst, Business Analysis, J&J Pharmaceutical Services LLC, New Brunswick, NJ (1999-2007) Pharmaceutical analysis expert supporting a team of 50+ professionals in Global Business Development and Licensing. Recognized expert in anti-infectives/anti-virals, oncology, central nervous system, respiratory, metabolics, and cardiovascular. Responsible for Japan and Europe.  Evaluated licensing opportunities and merger/acquisition candidates. Summarized global analyses from business, R&D disciplines, and presented specific recommendations to senior corporate management.  Developed and leveraged an extensive internal network of industry and Subject Matter Experts (SME).  Researched, recommended, negotiated, and managed contracts with vendors for databases.  Achieved Encore Award for teamwork, sense of urgency, and quality.

Information Consultant II, J&J Pharmaceutical R&D LLC, Raritan, NJ (1997-1999) Expert analyst skilled in conducting competitive research on pipelines and companies for Research/Discovery Leaders and the Executive Board. Collaborated with the Corporate VP of Business Development to support new opportunities, licensing and acquisitions. Partnered with US and International VPs to facilitate local initiatives and support various therapeutic areas.  Identified licensing opportunities for the Diabetes Franchise which directly led to compound in-licensing. Promoted to business analysis role as a result of expertise and contributions.  Recruited and trained search staff building the department and ensuring quality. JILL MARIE FIELDHOUSE Page 2

THE DUNN GROUP, Totowa, NJ 1996-1997 Senior Research Analyst Conducted discrete competitive assessments for client pharmaceutical companies. Interviewed senior management, scientists, investment bankers, and investor relations representatives to gather competitive intelligence and insights into specific therapeutic areas, indications, medical/treatment issues, pipeline, products, and line extensions. Projects included: preclinical, clinical, regulatory, marketing, and managed care components.  Performed analyses of diversified marketplaces by obtaining, analyzing, compiling, and presenting scientific and business solutions to the clients. Collected primary and secondary data, conducted primary research and secondary on-line database searches.  Recommended strategic solutions to clients facing complex organizational challenges in the pharmaceutical, biotechnology, and managed care industries.  Attended key scientific industry meetings/conferences to conduct breaking competitive/scientific intelligence.  Built relationships and leveraged a network of industry thought leaders and SME.  Recognized SME providing analysis and industry guidance to colleagues.

HOFFMANN-LA ROCHE, Nutley, NJ 1992-1996 Manager, Regulatory Information Led the development of a key global regulatory information system/relational database, familiar with System Development Lifecycle Process. Recruited, hired, trained, and managed a team of 10 Database Administrators and external consultants to meet project objectives. Prepared new job descriptions and conducted annual performance evaluations. Responsible for regulatory intelligence with one additional direct report. Awarded Management Incentive Bonus.  Corporate Project Team Leader charged with designing and implementing a $5 Million archival and retrieval global regulatory information system. o Collaborated with external consultants to identify, request proposals, review bids, evaluate and select components from different vendors to link to new relational database. o Created a streamlined, cost-effective access to paper-based and on-line electronic regulatory information. o Partnered to achieve successful rollout and implementation.  Reengineered workflows for the Data Administration Group and File/Mail Room Administrators increasing productivity by 20%.  Recommended system enhancements and design changes; reduced document searching and retrieving activity time by 50%, and reduced communication time with the FDA by 30%.

MERCK & CO., INC., Rahway, NJ 1988-1992 Labeling/Senior Documentation Specialist Liaison interacting with International Medical Directors and VP-level Managers from various departments across Merck. Analyzed, researched, and resolved issues related to international labeling for physician circulars and patient package inserts. Interacted with International Physician Circular Review Committee to raise issues and expedite the approval process of various departments (Marketing, Regulatory Affairs, Legal, Clinical, and Medical and Scientific Affairs).  Accelerated the international prescribing information approval cycle by more than 50%. Awarded VP Discretionary recognition.  Achieved two additional Discretionary Awards for contributions over and above to the Department. 1) Recognized as one of the first Junior Scientists to receive this award. 2) Received for lead identification, and membrane assay establishment.

EDUCATION MBA, Computer & Information Systems, Rutgers University Graduate School of Management, Newark, NJ BA, Major: Botany & Minor: Chemistry, Summa Cum Laude/Phi Beta Kappa, Rutgers University, Newark, NJ

Recommended publications